Insulin resistance-induced hypertension and a role of perivascular CGRPergic nerves

Current Protein and Peptide Science

Volumn 14, Issue 4, 2013, Pages 275-281

  Takatori, Shingo ^a,c   Zamami, Yoshito ^a   Hashikawa Hobara, Narumi ^b   Kawasaki, Hiromu ^a,c  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

^c MATSUYAMA UNIVERSITY   (Japan)

Author keywords

Hyperglycemia; Hyperinsulinemia; Hypertension; Insulin resistance; Perivascular CGRPergic nerves; Perivascular sympathetic adrenergic nerves

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; HEMOGLOBIN A1C; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; VANILLOID RECEPTOR;

ARTICLE; BLOOD VESSEL REACTIVITY; DISEASE ASSOCIATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; SPINAL CORD STIMULATION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; HYPERTENSION; INSULIN RESISTANCE; VASOMOTOR SYSTEM;

EID: 84888223854     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/13892037113149990047     Document Type: Article

References (74)

1. Okuno, A.; Tamemoto, H.; Tobe, K.; Ueki, K.; Mori, Y.; Iwamoto, K.; Umesono, K.; Akanuma, Y.; Fujiwara, T.; Horikoshi, H.; Yazaki, Y.; Kadowaki, T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest., 1998, 101(6), 1354-1361.
2. Yamauchi, T.; Kamon, J.; Waki, H.; Murakami, K.; Motojima, K.; Komeda, K.; Ide, T.; Kubota, N.; Terauchi, Y.; Tobe, K.; Miki, H.; Tsuchida, A.; Akanuma, Y.; Nagai, R.; Kimura, S.; Kadowaki, T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem., 2001, 276(44), 41245-41254.
3. Yamauchi, T.; Kamon, J.; Waki, H.; Terauchi, Y.; Kubota, N.; Hara, K.; Mori, Y.; Ide, T.; Murakami, K.; Tsuboyama-Kasaoka, N.; Ezaki, O.; Akanuma, Y.; Gavrilova, O.; Vinson, C.; Reitman, M.L.; Kagechika, H.; Shudo, K.; Yoda, M.; Nakano, Y.; Tobe, K.; Nagai, R.; Kimura, S.; Tomita, M.; Froguel, P.; Kadowaki, T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 2001, 7(8), 941-946.
4. Warram, J.H.; Martin, B.C.; Krolewski, A.S.; Soeldner, J.S.; Kahn, C.R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann. Intern. Med., 1990, 113(12), 909-915.
5. Lillioja, S.; Mott, D.M.; Spraul, M.; Ferraro, R.; Foley, J.E.; Ravussin, E.; Knowler, W.C.; Bennett, P.H.; Bogardus, C. Insulin resistance and insulin secretory dysfunction as precursors of noninsulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med., 1993, 329(27), 1988-1992.
6. Pollare, T.; Lithell, H.; Berne, C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism, 1990, 39(2), 167-174.
7. Raitakari, O.T.; Porkka, K.V.; Rönnemaa, T.; Knip, M.; Uhari, M.; Akerblom, H.K.; Viikari, J.S. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. Diabetologia, 1995, 38(9), 1042-1050.
8. Allemann, Y.; Horber, F.F.; Colombo, M.; Ferrari, P.; Shaw, S.; Jaeger, P.; Weidmann, P. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet, 1993, 341(8841), 327-331.
9. Pyorala, K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes. Care., 1979, 2(2), 131-141.
10. Lima, N.K.; Abbasi, F.; Lamendola, C.; Reaven, G.M. Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am. J. Hypertens., 2009, 22(1), 106-111.
11. Zavaroni, I.; Mazza, S.; Dall'Aglio, E.; Gasparini, P.; Passeri, M.; Reaven, G.M. Prevalence of hyperinsulinaemia in patients with high blood pressure. J. Intern. Med., 1992, 231(3), 235-240.
12. Lembo, G.; Napoli, R.; Capaldo, B.; Rendina, V.; Iaccarino, G.; Volpe, M.; Trimarco, B.; Saccà, L. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J. Clin. Invest., 1992, 90(1), 24-29.
13. Defronzo, R.A. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia, 1981, 21(3), 165-171.
14. Hsueh, W.A.; Law, R.E. Insulin signaling in the arterial wall. Am. J. Cardiol., 1999, 84(1A), 21J-24J.
15. Zeng, G.; Nystrom, F.H.; Ravichandran, L.V.; Cong, L.N.; Kirby, M.; Mostowski, H.; Quon, M.J. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation, 2000, 101(13), 1539-1545.
16. Mimaki, Y.; Kawasaki, H.; Okazaki, M.; Nakatsuma, A.; Araki, H.; Gomita, Y. Involvement of calcitonin gene-related peptide (CGRP) receptors in insulin-induced vasodilatation in mesenteric resistance blood vessels of rats. Br. J. Pharmacol., 1998, 123(8), 1684-1690.
17. Fuller, J.H.; Shipley, M.J.; Rose, G.; Jarrett, R.J.; Keen, H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet, 1980, 1(8183), 1373-1376.
18. Yamagishi, S.; Matsui, T.; Ueda, S.; Fukami, K.; Okuda, S. Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disorders. Curr. Drug. Metab., 2009, 10(2), 159-163.
19. Kuusisto, J.; Mykkänen, L.; Pyörälä, K.; Laakso, M. Non-insulindependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke, 1994, 25(6), 1157-1164.
20. Quagliaro, L.; Piconi, L.; Assaloni, R.; Da Ros, R.; Maier, A.; Zuodar, G.; Ceriello, A. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis, 2005, 183(2), 259-267.
21. Quagliaro, L.; Piconi, L.; Assaloni, R.; Martinelli, L.; Motz, E.; Ceriello, A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes, 2003, 52(11), 2795-2804.
22. Monnier, L.; Mas, E.; Ginet, C.; Michel, F.; Villon, L.; Cristol, J.P.; Colette, C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA., 2006, 295(14), 1681-1687.
23. Yu, P.C.; Bosnyak, Z.; Ceriello, A. The importance of glycated haemoglobin (HbA(1c) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. Diabetes. Res. Clin. Pract., 2010, 89(1), 1-9.
24. Yamagishi, S. Advanced glycation end products and receptoroxidative stress system in diabetic vascular complications. Ther. Apher. Dial., 2009, 13(6), 534-539.
25. Yamagishi, S.; Nakamura, K.; Matsui, T.; Ueda, S.; Fukami, K.; Okuda, S. Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications. Expert. Opin. Investig. Drugs., 2008, 17(7), 983-996.
26. Eguchi, S.; Tezuka, S.; Hobara, N.; Akiyama, S.; Kurosaki, Y.; Kawasaki, H. Vanilloid receptors mediate adrenergic nerve-and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries. Br. J. Pharmacol., 2004, 142(7), 1137-1146.
27. Tippins, J.R. CGRP: a novel neuropeptide from the calcitonin gene is the most potent vasodilator known. J. Hypertens. Suppl., 1986, 4(5), S102-S105.
28. Wimalawansa, S.J. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr. Rev., 1996, 17, 533-585.
29. Mulderry, P.K.; Ghatei, M.A.; Spokes, R.A.; Jones, P.M.; Pierson, A.M.; Hamid, Q.A.; Kanse, S.; Amara, S.G.; Burrin, J.M.; Legon, S.; Polak, J.M.; Bloom, S.R. Differential expression of alfa-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience., 1988, 25(1), 195-205.
30. Kawasaki, H.; Nuki, C.; Saito, A.; Takasaki, K. Role of calcitonin gene-related peptide-containing nerves in the vascular adrenergic neurotransmission. J. Pharmacol. Exp. Ther., 1990, 252(1), 403-409.
31. Kawasaki, H.; Nuki, C.; Saito, A.; Takasaki, K. Adrenergic modulation of calcitonin gene-related peptide (CGRP)-containing nervemediated vasodilation in the rat mesenteric resistance vessel. Brain. Res., 1990, 506(2), 287-290.
32. Takatori, S.; Mizote, M.; Zamami, Y.; Kurosaki, Y.; Kawasaki, H. Effects of insulin on vascular responses to spinal cord stimulation and vasoactive agents in pithed rats. Br. J. Pharmacol., 2003, 140(6), 1137-1145.
33. Li, C.; Ford, E.S.; McGuire, L.C.; Mokdad, A.H.; Little, R.R.; Reaven, G.M. Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes. Care., 2006, 29(11), 2396-2402.
34. Lardinois, C.K.; Mazzaferri, E.L.; Starich, G.H.; Hollenbeck, C.B.; Reaven, G.M. Increased gastric inhibitory polypeptide is not reduced in patients with noninsulin-dependent diabetes mellitus treated with intense insulin therapy. J. Clin. Endocrinol. Metab., 1985, 61(6), 1089-1092.
35. Anderson, E.A.; Hoffman, R.P.; Balon, T.W.; Sinkey, C.A.; Mark, A.L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest., 1991, 87(6), 2246-2252.
36. Sauter, A.; Goldstein, M.; Engel, J.; Ueta, K. Effect of insulin on central catecholamines. Brain. Res., 1983, 260(2), 330-333.
37. Anderson, E.A.; Mark, A.L. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension, 1993, 21(2), 136-141.
38. Scherrer, U.; Sartori, C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation, 1997, 96(11), 4104-4113.
39. Chiasson, J.L.; Josse, R.G.; Gomis, R.; Hanefeld, M.; Karasik, A.; Laakso, M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA, 2003, 290(4), 486-494.
40. Zeymer, U. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes. Int. J. Cardiol., 2006, 107(1), 11-20.
41. Zamami, Y.; Takatori, S.; Yamawaki, K.; Miyashita, S.; Mio, M.; Kitamura, Y.; Kawasaki, H. Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats. Hypertens. Res., 2008, 31(5), 1033-1044.
42. Hoffman, R.P.; Hausberg, M.; Sinkey, C.A.; Anderson, E.A. Hyperglycemia without hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Diabetes. Complications., 1999, 13(1), 17-22.
43. Verma, S.; Bhanot, S.; Yao, L.; McNeill, J.H. Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am. J. Hypertens., 1996, 9(4 Pt 1), 370-376.
44. Sakamoto, S.; Minami, K.; Niwa, Y.; Ohnaka, M.; Nakaya, Y.; Mizuno, A.; Kuwajima, M.; Shima, K. Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous NIDDM. Diabetes, 1998, 47(1), 82-86.
45. Kobayashi, T.; Kamata, K. Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Atherosclerosis, 2001, 155(2), 313-320.
46. Vanhoutte, P.M.; Shimokawa, H.; Tang, E.H.; Feletou, M. Endothelial dysfunction and vascular disease. Acta Physiol., (Oxf), 2009, 196(2), 193-222.
47. Uusitupa, M.I.; Niskanen, L.K.; Siitonen, O.; Voutilainen, E.; Pyörälä, K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (noninsulin-dependent) diabetic and non-diabetic subjects. Diabetologia, 1993, 36(11), 1175-1184.
48. D'Angelo, G.; Elmarakby, A.A.; Pollock, D.M.; Stepp, D.W. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension, 2005, 46(4), 806-811.
49. Zamami, Y.; Takatori, S.; Hobara, N.; Yabumae, N.; Tangsucharit, P.; Jin, X.; Hashikawa, N.; Kitamura, Y.; Sasaki, K.; Kawasaki, H. Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries. Hypertens. Res., 2011, 34(11), 1190-1196.
50. Takatori, S.; Zamami, Y.; Yabumae, N.; Hanafusa, N.; Mio, M.; Egawa, T.; Kawasaki, H. Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia. Br. J. Pharmacol., 2008, 153(7), 1388-1398.
51. De Jongh, R.T.; Serne, E.H.; Ijzerman, R.G.; De Vries, G.; Stehouwer, C.D. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation, 2004, 109, 2529-2535.
52. Lteif, A.; Mather, K. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages. Can. J. Cardiol., 2004, 20 (Suppl B), 66B-76B.
53. Hasegawa, K.; Yoshida, H.; Ura, N.; Murakami, H.; Hagiwara, M.; Shimamoto, K. The role of renal natriuretic and depressor systems in insulin-resistant hypertensive rats. Hypertens. Res., 2004, 27, 501-508.
54. Takatori, S.; Zamami, Y.; Mio, M.; Kurosaki, Y.; Kawasaki, H. Chronic hyperinsulinemia enhances adrenergic vasoconstriction and decreases calcitonin gene-related peptide-containing nervemediated vasodilation in pithed rats. Hypertens. Res., 2006, 29(5), 361-368.
55. Kawasaki, H.; Takasaki, K.; Saito, A.; Goto, K. Calcitonin generelated peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature, 1988, 335(6186), 164-167.
56. Kawasaki, H.; Nuki, C.; Saito, A.; Takasaki, K. NPY modulates neurotransmission of CGRP-containing vasodilator nerves in rat mesenteric arteries. Am. J. Physiol., 1991, 261(3 Pt 2), H683-H690.
57. Sugimoto, K.; Murakawa, Y.; Sima, A.A. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J. Periph. Nerv. Syst., 2002, 7(1), 44-53.
58. Sathianathan, V.; Avelino, A.; Charrua, A.; Santha, P.; Matesz, K.; Cruz, F.; Nagy, I. Insulin induces cobalt uptake in a subpopulation of rat cultured primary sensory neurons. Eur. J. Neurosci., 2003, 18(9), 2477-2486.
59. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 1997, 389(6653), 816-824.
60. Guo, A.; Vulchanova, L.; Wang, J.; Li, X.; Elde, R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J. Neurosci., 1999, 11(3), 946-958.
61. Michael, G.J.; Priestley, J.V. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J. Neurosci., 1999, 19(5), 1844-1854.
62. Hobara, N.; Goda, M.; Hashikawa, N.; Jin, X.; Zamami, Y.; Takatori, S.; Kawasaki, H. Role of angiontensin receptors in remodeling perivascular nerves. Yakugaku Zasshi, 2010, 130(11), 1421-1425.
63. Hashikawa-Hobara, N., Hashikawa, N., Inoue, Y., Sanda, H., Zamami, Y., Takatori, S., Kawasaki, H. Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats. Diabetes., 2012, 61(4), 925-932.
64. Jin, X.; Amitani, K.; Zamami, Y.; Takatori, S.; Hobara, N.; Kawamura, N.; Hirata, T.; Wada, A.; Kitamura, Y.; Kawasaki, H. Ameliorative effect of Eucommia ulmoides Oliv. leaves extract (ELE) on insulin resistance and abnormal perivascular innervation in fructose-drinking rats. J. Ethnopharmacol., 2010, 128(3), 672-678.
65. Zamami, Y.; Takatori, S.; Goda, M.; Koyama, T.; Iwatani, Y.; Jin, X.; Takai-Doi, S.; Kawasaki, H. Royal jelly ameliorates insulin resistance in fructose-drinking rats. Bio. Pharm. Bull., 2008, 31(11), 2103-2107.
66. Zamami, Y.; Fujiwara, H.; Hosoda, M.; Hino, H.; Hirai, K.; Okamoto, K.; Jin, X.; Takatori, S.; Doi-Takaki, S.; Kawasaki, H. Ameliorative effect of propolis on insulin resistance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Yakugaku Zasshi, 2010, 130(6), 833-840.
67. Kawano, K.; Hirashima, T.; Mori, S.; Saitoh, Y.; Kurosumi, M.; Natori, T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes, 1992, 41(11), 1422-1428.
68. Shima, K.; Zhu, M.; Mizuno, A. Pathoetiology and prevention of NIDDM lessons from the OLETF rat. J. Med. Invest., 1999, 46(3-4), 121-129.
69. De Vriese, A.S.; Verbeuren, T.J.; Van de Voorde, J.; Lameire, N.H.; Vanhoutte, P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol., 2000, 130(5), 963-974.
70. Muniyappa, R.; Montagnani, M.; Koh, K.K.; Quon, M.J. Cardiovascular actions of insulin. Endocr. Rev., 2007, 28(5), 463-491.
71. Meigs, J.B.; O'donnell, C.J.; Tofler, G.H.; Benjamin, E.J.; Fox, C.S.; Lipinska, I.; Nathan, D.M.; Sullivan, L.M.; D'Agostino, R.B.; Wilson, P.W. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes, 2006, 55(2), 530-537.
72. Matsumoto, T.; Ishida, K.; Kobayashi, T.; Kamata, K. Pyrrolidine dithiocarbamate reduces vascular prostanoid-induced responses in aged type 2 diabetic rat model. J. Pharmacol. Sci., 2009, 110(3), 326-333.
73. Matsumoto, T.; Takaoka, E.; Ishida, K.; Nakayama, N.; Noguchi, E.; Kobayashi, T.; Kamata, K. Abnormalities of endotheliumdependent responses in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats are improved by chronic treatment with thromboxane A2 synthase inhibitor. Artherosclerosis, 2009, 205(1), 87-95.
74. Matsumoto, T.; Noguchi, E.; Ishida, K.; Nakayama, N.; Kobayashi, T.; Kamata, K. Cilostazol improves endothelial dysfunction by increasing endothelium-derived hyperpolarizing factor response in mesenteric arteries from Type 2 diabetic rats. Eur. J. Pharmacol., 2008, 599(1-3), 102-109.